Rol actual de los nuevos antiplaquetarios en el síndrome coronario agudo

Ramon-Corbalan
Ramón Corbalan
2011-08-03

More articles by this author

Antiplatelet therapy advance in ACS and PCI

Jorge Belardi 2011-08-05

Protección gástrica en pacientes sometidos a angioplastia coronaria

Gastón Dussaillant 2011-08-03

Therapeutic strategies for the control of dyslipemia

Ada Cuevas 2011-08-03

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...